# **Is Perineural Injection Therapy Training Right for You? A Guide for Doctors, Physios & Allied Health Pros**

For Doctors · Physios · Allied Health Professionals
There's a moment most clinicians recognize: a patient comes back for the fourth or fifth visit, still in pain, still frustrated, and you've exhausted your standard toolkit. You've tried everything you reasonably can — and yet something clearly isn't resolved at the tissue level. For many practitioners, that moment is what leads them to ask harder questions about how pain actually works.

**[perineural injection therapy training](https://www.learnneuraltherapy.com/)** is one of the answers those questions have surfaced. It's not experimental, it's not fringe, and it's not a replacement for what you already know. But it is a technique that's quietly reshaping how forward-thinking clinicians approach chronic pain, nerve hypersensitivity, and soft tissue dysfunction — and the demand for proper training is growing fast.

So if you're a physician, physical therapist, chiropractor, nurse practitioner, or any allied health professional wondering whether this skill set belongs in your practice — this guide is for you.

**What Is Perineural Injection Therapy, Really?**

At its core, PIT is a regenerative injection technique developed by New Zealand physician Dr. John Lyftogt. It involves injecting small amounts of dextrose solution (typically 5%) subcutaneously along the course of peripheral nerves to address nerve hypersensitivity — a condition increasingly recognized as a major driver of chronic musculoskeletal pain.

The mechanism matters here. Unlike corticosteroids that suppress inflammation, or prolotherapy that targets ligament laxity, PIT specifically targets neurogenic inflammation — the kind driven by sensitized, misfiring peripheral nerves. When a nerve is injured, compressed, or chronically irritated, it can enter a hypersensitive state, releasing substance P and other neuropeptides that perpetuate pain cycles independent of the original injury site.

"Most of our chronic pain patients don't have a tissue problem. They have a nerve problem that's been missed because we weren't trained to look for it."

PIT works by bathing those superficial nerve segments in a dextrose solution that appears to normalize nerve membrane function — reducing that hypersensitive firing and, in many cases, providing rapid, lasting pain relief that traditional interventions couldn't achieve.

**Where Does It Fit in Modern Pain Management?**

The shift in pain science over the past decade has been significant. Central sensitization, neuroinflammation, and the neurobiological basis of chronic pain are no longer theoretical concepts — they're clinical realities that demand different tools. PIT fits squarely into this evolving framework, offering a targeted, low-risk intervention that bridges the gap between manual therapy and more invasive procedures.

It's particularly valuable in patients with persistent pain after "successful" surgeries, those with complex regional pain syndrome features, athletes with recurrent tendinopathies, and anyone whose pain pattern doesn't map neatly to a structural diagnosis on imaging.

**Who Should Consider PIT Training?**

The honest answer? A broader range of practitioners than you might expect. The technique is trainable across multiple disciplines, and the ability to perform perineural injections — or at minimum, to understand the neurogenic component of a patient's pain — is valuable whether you're holding a syringe or not.

**Medical Doctors & Osteopaths**
If you're already performing injections — trigger point, joint, prolotherapy, or nerve blocks — PIT adds a relatively low-barrier skill with a strong evidence base in neuropathic and musculoskeletal pain. It can meaningfully change outcomes for patients you've been managing for months without satisfying results.

**Physical Therapists & Chiropractors**
Even in states where PTs cannot independently perform injections, understanding PIT's mechanism reframes how you assess and treat. Recognizing a cutaneous nerve hypersensitivity pattern changes your manual therapy approach. In states with dry needling or expanded PT scope, PIT training can be directly applicable to your practice with appropriate legal review.

**Nurse Practitioners & Physician Assistants**
NPs and PAs operating in integrative, sports medicine, or pain management settings are increasingly adopting PIT as part of a multi-modal toolkit. With appropriate supervision or independent practice authority depending on state, this is one of the more impactful procedural skills available through continuing education.

**Who Benefits Most from PIT Training:**

* Practitioners treating post-surgical or post-injury chronic pain
* Sports medicine clinicians managing tendinopathy and soft tissue injuries
* Integrative or functional medicine providers
* Any clinician seeing patients who've "tried everything"
* Those looking to differentiate their practice with a neurogenic approach

**What Good PIT Training Actually Looks Like**

Not all injection training is created equal. The difference between a weekend course that leaves you theoretically informed and hands-on training that leaves you clinically ready is significant — and it matters for patient safety and outcomes alike.

Quality PIT training should include a grounding in the neuroanatomy relevant to superficial nerve mapping, hands-on injection practice with supervision, case-based learning that reflects real patient presentations, and a framework for integrating PIT into your existing clinical workflow rather than treating it as an isolated technique.

Platforms like Learn Neural Therapy have emerged to meet this demand, offering structured, evidence-informed curricula specifically designed for the clinical realities of working practitioners in the USA. Rather than generic injection courses, programs through Learn Neural Therapy focus on the intersection of neural mechanisms and practical injection technique — which is exactly where the learning curve is steepest and where quality mentorship matters most.

**The Workshop Experience: What to Expect**

Expect to work through surface anatomy in a hands-on setting, practice needle placement on live models or simulators, and engage in clinical case discussions that mirror the complexity of your actual patient population. Good workshops don't just teach you how to inject — they teach you when PIT is indicated, when it isn't, and how to explain the rationale to patients in plain language.

The practitioner feedback from these sessions consistently highlights one surprise: how quickly proficiency builds when the instruction bridges neuroscience theory with technical skill simultaneously, rather than separating them.

**Integrating PIT Into Your Current Practice**

One of the most practical concerns practitioners have is workflow. How does this fit alongside what I already do? The answer depends on your setting, but PIT is notably integrable precisely because sessions are brief — often 15 to 30 minutes — and the dextrose solution is low-cost and widely available.

Many clinicians begin by applying PIT to a small subset of their existing chronic pain patients — those with nerve tenderness on palpation, pain out of proportion to structural findings, or a history of failed conventional treatments. The results in that subset often generate organic word-of-mouth referrals and quickly demonstrate the technique's value within the practice context.

Billing and coding for PIT varies by state and payer, so it's worth reviewing current CPT guidance and considering a consultation with a healthcare billing specialist familiar with regenerative procedures. Some practitioners offer PIT under cash-pay or integrative medicine billing structures, which simplifies the administrative side considerably.

**Frequently Asked Questions**

**Is PIT safe for patients with diabetes or other systemic conditions?**
The dextrose concentrations used in PIT (typically 5%) are well below glycemic-altering thresholds, and the technique has been used in diabetic neuropathy contexts with careful patient selection. That said, a thorough intake and contraindication screening is essential, and training programs should cover these clinical nuances in depth.

**Do I need prior injection experience to take a PIT training course**?
It depends on the program. Some courses are designed for experienced injectors looking to expand into neural techniques, while others — like those available through Learn Neural Therapy — offer tiered training appropriate for practitioners newer to injection-based procedures. Review course prerequisites carefully before enrolling.

**How many sessions does a patient typically need?**
Clinical response varies, but many patients with peripheral nerve hypersensitivity see meaningful improvement within three to six sessions. Some acute presentations resolve faster; complex chronic cases may require more. Part of good training is developing realistic patient communication around expected timelines.

**Is there peer-reviewed evidence supporting PIT?**
Yes. The evidence base includes randomized controlled trials in conditions like lateral epicondylitis, knee osteoarthritis, plantar fasciitis, and Achilles tendinopathy, among others. Dr. Lyftogt's original research and subsequent clinical studies provide a reasonable evidentiary foundation, though as with most injection therapies, larger trials remain an active research area.

**What's the difference between PIT and standard prolotherapy?**
Both use dextrose, but the target and mechanism differ significantly. Prolotherapy traditionally targets ligament and tendon attachments at higher concentrations to stimulate a local healing response. PIT uses lower concentrations delivered subcutaneously along peripheral nerve paths, targeting nerve hypersensitivity rather than connective tissue repair. They're complementary rather than competing techniques.

**Final Thoughts: Is This the Right Next Step?**
If your practice includes patients with chronic pain that hasn't fully resolved — and whose doesn't? — then the neuroscience behind PIT is worth understanding whether or not you ultimately pursue injection training. The shift toward recognizing peripheral nerve hypersensitivity as a primary pain driver is one of the most clinically actionable developments in pain medicine in years.

For practitioners ready to go further, proper training through a structured, hands-on program is non-negotiable. The technique is teachable, the evidence is credible, and the patient population that stands to benefit is large. Resources like Learn Neural Therapy exist precisely to support that transition — with curricula built by and for clinicians who take both the science and the skill seriously.

Pain management is evolving. The practitioners who will define the next decade of care are the ones asking the questions you're asking right now.